“…Many such firms have transformed themselves to be globally competitive, responding to institutional transitions and the resulting ecosystem changes in their home markets over recent decades (Cuervo-Cazurra & Genc, 2008; Ramamurti, 2012a). Because innovations are embedded in institutional contexts, the country-specific triggers and drivers of innovation processes are important (Chittoor, Aulakh, & Ray, 2015; Peng, Ahlstrom, Carraher, & Shi, 2017; Thakur-Wernz & Samant, 2017). The strength of the intellectual property (IP) regime is one such trigger, playing a key role in driving innovation in knowledge-intensive industries such as pharmaceuticals (Brandl, Darendeli, & Mudambi, 2019; Kale & Wield, 2008; Papageorgiadis & McDonald, 2019).…”